These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6334193)

  • 1. [Prostatic cytoplasmic androgen receptor in prostatic disease. II. Correlation between clinical response to hormonal therapy and change of R1881 receptor content in prostatic cancer during antiandrogenic therapy].
    Kitano T
    Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1098-108. PubMed ID: 6334193
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor assays in advanced prostatic cancer.
    Buttyan R; Olsson CA
    Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic cytoplasmic androgen receptor in prostatic disease. I. Serum androgen levels, cytoplasmic androgen levels and cytoplasmic R1881 receptor in prostatic disease].
    Kitano T
    Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1084-97. PubMed ID: 6334192
    [No Abstract]   [Full Text] [Related]  

  • 5. Androgen receptor content of the normal and hyperplastic canine prostate.
    Shain SA; Boesel RW
    J Clin Invest; 1978 Mar; 61(3):654-60. PubMed ID: 76635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
    Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
    Habib FK; Chisholm GD
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of estrogen, androgen and progestogen receptors in the management of carcinoma of the prostate.
    Young JD; Sidh SM; Bashirelahi N
    Trans Am Assoc Genitourin Surg; 1979; 71():23-5. PubMed ID: 545809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
    Barrack ER; Bujnovszky P; Walsh PC
    Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer.
    Walsh PC; Greco JM; Tananis CE; Hicks LL; McLoughlin MG; Menon M
    Trans Am Assoc Genitourin Surg; 1977; 69():78-80. PubMed ID: 84428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications and value of receptor levels in treatment of prostate cancer.
    Connolly JG; Mobbs BG
    Prostate; 1984; 5(5):477-83. PubMed ID: 6384975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between clinical response to hormone therapy and steroid receptor content in prostatic cancer.
    Gustafsson JA; Ekman P; Snochowski M; Zetterberg A; Pousette A; Högberg B
    Cancer Res; 1978 Nov; 38(11 Pt 2):4345-8. PubMed ID: 698975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exchange assay for androgen receptors in the presence of molybdate.
    Carroll SL; Rowley DR; Chang CH; Tindall DJ
    J Steroid Biochem; 1984 Oct; 21(4):353-9. PubMed ID: 6387280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of the determination of receptors in carcinoma of the prostate].
    Castellanos JM; Galán A; Calvo MA; Schwartz S
    Rev Esp Oncol; 1984; 31(2):265-77. PubMed ID: 6085864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 16. Androgen cytosol binding during compensatory overload-induced skeletal muscle hypertrophy.
    Hickson RC; Kurowski TT; Galassi TM; Daniels DG; Chatterton RJ
    Can J Biochem Cell Biol; 1985 May; 63(5):348-54. PubMed ID: 3874677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of correlations between therapeutic efficacy of anti-androgen therapy in prostatic cancer and androgen receptor content of prostatic cancer tissue].
    Ohno K; Umehara T; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1984 Aug; 75(8):1212-24. PubMed ID: 6513222
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
    Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
    Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
    [No Abstract]   [Full Text] [Related]  

  • 19. Androgen modulation of prostate cancer cell androgen receptor content is cell line specific.
    Lin AL; Shain SA
    Mol Cell Endocrinol; 1989 May; 63(1-2):75-83. PubMed ID: 2787764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human prostate androgen receptor quantitation: effects of temperature on assay parameters.
    Shain SA; Gorelic LS; Boesel RW; Radwin HM; Lamm DL
    Cancer Res; 1982 Nov; 42(11):4849-54. PubMed ID: 6982098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.